| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.052 | 0.3 |